794702

Vertex Pharmaceuticals Incorporated — FEI 1000513211

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 2, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)